About Us 

Challenge IM is focusing on developing, manufacturing, selling, and servicing membrane filtration systems for the biopharmaceutical industry. It has diversified its product lines to support laboratory, pilot, and large-scale production, offering commercial and customized solutions that meet customer and market needs. Its fully automated, unattended tangential flow filtration system fills a significant gap in both domestic and international markets, driving global technological innovation. These products are now widely used across various biopharmaceutical sectors, including antibodies, vaccines, nucleic acid drugs, cell therapy, and gene therapy.

Challenge IM upholds the belief of ‘Challenge Leads  Achievements' committed to producing exceptional products, nurturing outstanding talent, and empowering users to become leaders in their field. Strength is demonstrated through quality, and the market is established through service. The company has now partnered with numerous renowned biopharmaceutical enterprises worldwide.

Work with us to advance biopharmaceutical technology and make a meaningful impact on global health.